Effects of oral antibiotic roxithromycin on quality of life in acne patients

Journal of Dermatology

Volumn 36, Issue 7, 2009, Pages 383-391

  Kobayashi, Miwa ^a   Kabashima, Kenji ^a   Nakamura, Motonobu ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Acne; Macrolide; Quality of life; Roxithromycin

Indexed keywords

ROXITHROMYCIN;

ACNE; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; EMOTION; FACE; FEMALE; HEALTH SURVEY; HUMAN; HUMAN RELATION; LEISURE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL; SYMPTOM; TREATMENT OUTCOME; WORK;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; ROXITHROMYCIN; YOUNG ADULT;

EID: 67651204759     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00664.x     Document Type: Article

References (22)

1. Strauss JS, Krowchuk DP, Leyden JJ et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007 56 : 651 663. (Pubitemid 46400177)
2. Stern RS. The prevalence of acne on the basis of physical examination. J Am Acad Dermatol 1992 26 : 931 935.
3. Strauss JS. Skin care and incidence of skin disease in adolescence. Curr Med Res Opin 1982 7 : 33 45. (Pubitemid 12040139)
4. Mallon E, Newton JN, Klassen A et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999 140 : 672 676. (Pubitemid 29191387)
5. Higaki Y, Kawamoto K, Kamo T et al. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol 2002 29 : 693 698. (Pubitemid 35416255)
6. Takahashi N, Suzukamo Y, Nakamura M et al. Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne. Health Qual Life Outcomes 2006 4 : 46.
7. Hayashi N, Akamatsu H, Kawashima M. Establishment of grading criteria for acne severity. J Dermatol 2008 35 : 255 260. (Pubitemid 351678090)
8. Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications. proposed mechanisms of action. Pharmacol Ther 2008 117 : 393 405.
9. Tokura Y, Kobayashi M, Kabashima K. Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals. Exp Dermatol 2008 17 : 81 90.
10. Ohshima A, Tokura Y, Wakita H et al. Roxithromycin down-modulates antigen-presenting and interleukin-1 beta-producing abilities of murine Langerhans cells. J Dermatol Sci 1998 17 : 214 222. (Pubitemid 28341665)
11. Wakita H, Tokura Y, Furukawa F et al. The macrolide antibiotic, roxithromycin suppresses IFN-gamma-mediated immunological functions of cultured normal human keratinocytes. Biol Pharm Bull 1996 19 : 224 227. (Pubitemid 26088355)
12. Agen C, Danesi R, Blandizzi C et al. Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 1993 38 : 85 90. (Pubitemid 23100902)
13. Ohshima A, Takigawa M, Tokura Y. CD8+ cell changes in psoriasis associated with roxithromycin-induced clinical improvement. Eur J Dermatol 2001 11 : 410 415. (Pubitemid 32801335)
14. Horiuchi Y, Bae S, Katayama I. Uncontrollable prurigo nodularis effectively treated by roxithromycin and tranilast. J Drugs Dermatol 2006 5 : 363 365.
15. Ito S, Hatamochi A, Yamazaki S. A case of confluent and reticulated papillomatosis that successfully responded to roxithromycin. J Dermatol 2006 33 : 71 72.
16. Inui S, Nakajima T, Fukuzato Y et al. Potential anti-androgenic activity of roxithromycin in skin. J Dermatol Sci 2001 27 : 147 151. (Pubitemid 32781023)
17. Kobayashi M, Shimauchi T, Hino R et al. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell Immunol 2004 228 : 27 33. (Pubitemid 38760120)
18. Takahashi H, Hashimoto Y, Ishida-Yamamoto A et al. Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes. J Dermatol Sci 2005 39 : 175 182. (Pubitemid 41225382)
19. Komine M, Kakinuma T, Kagami S et al. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005 125 : 491 498.
20. Newton JN, Mallon E, Klassen A et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997 137 : 563 567. (Pubitemid 27469507)
21. Jones-Caballero M, Chren MM, Soler B et al. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol 2007 21 : 219 226. (Pubitemid 46128698)
22. Kawashima M, Akamastu H, Hayashi N et al. [Survey of the patients with acne at dermatological clinics.] Rinsho Hifuka 2008 62 : 673 682. (In Japanese.)